The Enzymatic Mutation Detection(TM) (EMD) assay detects mutations or
polymorphisms in DNA. The assay procedure takes <1 h and is followed b
y electrophoretic detection. We report an automated procedure, using f
luorescently labeled probe and quantitative analysis on the ABI Prism(
TM) 377 DNA Sequencer, that improves on earlier methods (1, 2) by elim
inating the need for sample purification, shortening the hybridization
time, and increasing the signal-to-noise ratio. The EMD assay uses th
e bacteriophage resolvase T-4 endonuclease VII, which cleaves the hete
roduplex molecules at the mismatch site, forming two shorter fragments
that are resolved by gel electrophoresis. Unlike existing mutation te
chniques, the EMD method uses a single protocol to identify point muta
tions, deletions, and insertions for all DNA fragments. Test DNA sampl
es are assayed directly from PCR reactions, and fragments up to 4 kb i
n size have been assayed successfully. A independent analysis on the p
53 tumor suppressor gene from clinical samples has shown 100% sensitiv
ity and 94% specificity. Because the fluorescent EMD assay has been op
timized for high signal-to-noise ratios, mutations can be identified i
n mixed samples containing up to a 20-fold excess of normal DNA.